Key study of Ketek drug may have included fraud, errors

05/1/2006 | Wall Street Journal, The

Sanofi-Aventis' respiratory infection drug Ketek has been linked to reports of severe liver damage, and now some documents are raising questions about possible fraud and errors in a clinical trial of the drug that was used in the application for FDA approval. The drug company defended the clinical trial and said Ketek is safe.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR